ETOPOSIDE PHOSPHATE

ETOPOSIDE PHOSPHATE was reported 1635 times

ETOPOSIDE PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GREY ZONE LYMPHOMA 3 0.3333
1 EARLY REPOLARISATION SYNDROME 2 0.2000
2 MEASLES POST VACCINE 2 0.1538
3 PREALBUMIN ABNORMAL 2 0.1333
4 PROCTITIS BACTERIAL 2 0.1250
5 HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA RECURRENT 2 0.1176
6 TESTIS CANCER RECURRENT 1 0.1000
7 SCOPULARIOPSIS INFECTION 4 0.0889
8 HEPATITIS G 2 0.0714
9 DILATATION INTRAHEPATIC DUCT ACQUIRED 20 0.0685
10 ANTITHROMBIN III DEFICIENCY 6 0.0674
11 CD19 ANTIGEN LOSS 1 0.0625
12 REFRACTORY CANCER 13 0.0610
13 ILIAC ARTERY PERFORATION 1 0.0588
14 PERINEPHRITIS 1 0.0588
15 T-CELL LYMPHOMA REFRACTORY 2 0.0571
16 ELECTROCARDIOGRAM HIGH VOLTAGE 1 0.0556
17 PROSTAGLANDIN ANALOGUE PERIORBITOPATHY 1 0.0556
18 MYELOCYTE PRESENT 2 0.0513
19 HUMAN HERPESVIRUS 6 VIRAEMIA 2 0.0500
20 DNA MISMATCH REPAIR PROTEIN GENE MUTATION 1 0.0417
21 PYODERMA STREPTOCOCCAL 1 0.0400
22 DOUBLE HIT LYMPHOMA 2 0.0400
23 T-CELL LYMPHOMA STAGE IV 2 0.0351
24 ACQUIRED POROKERATOSIS 1 0.0345
25 ACTINOMYCES BACTERAEMIA 1 0.0345
26 BRAIN SARCOMA 1 0.0333
27 LOSS OF CAR T-CELL PERSISTENCE 1 0.0333
28 CUTANEOUS B-CELL LYMPHOMA 2 0.0328
29 PLEURAL MASS 2 0.0328
30 CLONAL HAEMATOPOIESIS 2 0.0260
31 MARGINAL ZONE LYMPHOMA 5 0.0234
32 HIGH-GRADE B-CELL LYMPHOMA 4 0.0214
33 CAPNOCYTOPHAGA INFECTION 2 0.0213
34 APHERESIS 1 0.0200
35 PLASMABLASTIC LYMPHOMA 7 0.0196
36 LYMPHOMA TRANSFORMATION 7 0.0194
37 5Q MINUS SYNDROME 3 0.0187
38 CATHETER SITE OEDEMA 2 0.0183
39 GLUTAMATE DEHYDROGENASE INCREASED 2 0.0180
40 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA 2 0.0171
41 ACUTE MYELOMONOCYTIC LEUKAEMIA 4 0.0158
42 HAEMATOPOIETIC STEM CELL MOBILISATION 1 0.0156
43 MALIGNANT GENITOURINARY TRACT NEOPLASM 1 0.0149
44 PNEUMONIA ESCHERICHIA 5 0.0147
45 HAEMATOLOGICAL NEOPLASM 1 0.0145
46 CARDIOMYOPATHY ACUTE 3 0.0137
47 PHLEBOTOMY 1 0.0132
48 HYPOTONIC-HYPORESPONSIVE EPISODE 1 0.0128
49 OEDEMA DUE TO HEPATIC DISEASE 1 0.0125
50 ADMINISTRATION SITE OEDEMA 1 0.0116
51 LUNG ADENOCARCINOMA STAGE III 1 0.0115
52 HYDROSALPINX 1 0.0109
53 MONOCYTE PERCENTAGE DECREASED 2 0.0109
54 VENOOCCLUSIVE LIVER DISEASE 48 0.0097
55 HEPATIC ISCHAEMIA 3 0.0096
56 CONGENITAL APLASIA 3 0.0096
57 BURKITT'S LYMPHOMA 1 0.0095
58 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 21 0.0095
59 GAMMA-GLUTAMYLTRANSFERASE 1 0.0092
60 FEBRILE BONE MARROW APLASIA 39 0.0092
61 ENCEPHALITIS CYTOMEGALOVIRUS 4 0.0091
62 CEREBELLAR TUMOUR 1 0.0079
63 ILEITIS 3 0.0078
64 B-CELL APLASIA 2 0.0078
65 HYPERPROTEINAEMIA 2 0.0076
66 RESPIRATORY MONILIASIS 2 0.0075
67 INFUSION SITE THROMBOSIS 2 0.0075
68 B-CELL LYMPHOMA RECURRENT 4 0.0074
69 APLASIA 14 0.0071
70 HYPERCAPNIC COMA 1 0.0070
71 B-LYMPHOCYTE ABNORMALITIES 1 0.0070
72 TOOTH DEVELOPMENT DISORDER 1 0.0068
73 POLYCHROMASIA 2 0.0067
74 PROCEDURAL PNEUMOTHORAX 1 0.0065
75 VENOOCCLUSIVE DISEASE 16 0.0064
76 LACUNAR STROKE 2 0.0063
77 KLEBSIELLA SEPSIS 7 0.0062
78 CYTOMEGALOVIRUS CHORIORETINITIS 12 0.0061
79 SINUS ARRHYTHMIA 8 0.0061
80 DEVICE RELATED THROMBOSIS 6 0.0061
81 OCULAR VASCULITIS 1 0.0058
82 MULTIPLE PREGNANCY 1 0.0056
83 OPTIC ATROPHY 9 0.0055
84 RENAL ISCHAEMIA 3 0.0055
85 GASTROINTESTINAL TRACT ADENOMA 2 0.0055
86 HYDROCHOLECYSTIS 1 0.0054
87 DIFFUSE LARGE B-CELL LYMPHOMA 41 0.0053
88 RADIATION NECROSIS 3 0.0052
89 CATHETER SITE EXTRAVASATION 2 0.0050
90 BRONCHIAL FISTULA 1 0.0050
91 ABNORMAL CLOTTING FACTOR 1 0.0049
92 DEPERSONALISATION 4 0.0048
93 PSEUDOCELLULITIS 1 0.0047
94 ARTERIAL REPAIR 1 0.0046
95 PHRENIC NERVE PARALYSIS 1 0.0046
96 ANISOCYTOSIS 3 0.0046
97 SOFT TISSUE MASS 2 0.0043
98 NEUROLOGICAL DECOMPENSATION 10 0.0043
99 ZYGOMYCOSIS 2 0.0043
100 ADENOVIRAL HEPATITIS 1 0.0043
101 SPONTANEOUS BACTERIAL PERITONITIS 1 0.0041
102 ENTEROBACTER TEST POSITIVE 1 0.0041
103 EPIPHYSIOLYSIS 1 0.0040
104 OSTEOLYSIS 8 0.0039
105 PULMONARY MYCOSIS 3 0.0039
106 NEUTROPHIL PERCENTAGE DECREASED 2 0.0038
107 QUADRIPARESIS 6 0.0036
108 VENA CAVA THROMBOSIS 6 0.0036
109 RENAL TUBULAR DYSFUNCTION 2 0.0035
110 ENAMEL ANOMALY 1 0.0035
111 ADNEXA UTERI MASS 1 0.0035
112 HYPERLEUKOCYTOSIS 3 0.0034
113 ENGRAFTMENT SYNDROME 2 0.0034
114 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 2 0.0034
115 NEUTROPENIC COLITIS 7 0.0034
116 SINOATRIAL BLOCK 2 0.0034
117 LIVEDO RETICULARIS 7 0.0033
118 CANDIDA SEPSIS 3 0.0033
119 RESTRICTIVE CARDIOMYOPATHY 1 0.0033
120 PREMATURE MENOPAUSE 3 0.0032
121 STEM CELL TRANSPLANT 8 0.0032
122 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 1 0.0032
123 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 1 0.0032
124 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 3 0.0032
125 CHRONIC HEPATITIS B 1 0.0032
126 ACTINOMYCOSIS 3 0.0031
127 CNS VENTRICULITIS 1 0.0031
128 VULVITIS 1 0.0030
129 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 1 0.0030
130 DILATED CARDIOMYOPATHY 3 0.0030
131 BLOOD LACTATE DEHYDROGENASE ABNORMAL 2 0.0029
132 FIBROSIS 9 0.0029
133 VARICELLA ZOSTER VIRUS INFECTION 6 0.0029
134 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
135 PULMONARY TOXICITY 20 0.0028
136 CYTOMEGALOVIRUS HEPATITIS 1 0.0028
137 VIRAL HAEMORRHAGIC CYSTITIS 2 0.0028
138 SECOND PRIMARY MALIGNANCY 23 0.0028
139 VIRAL TEST POSITIVE 1 0.0028
140 VENOUS OCCLUSION 5 0.0027
141 SCAN ABNORMAL 1 0.0027
142 SHOCK SYMPTOM 1 0.0027
143 CARDIOTOXICITY 24 0.0027
144 DISSEMINATED CRYPTOCOCCOSIS 2 0.0026
145 SUBCLAVIAN VEIN THROMBOSIS 3 0.0026
146 COAGULATION TEST ABNORMAL 2 0.0026
147 DISSEMINATED MUCORMYCOSIS 1 0.0025
148 HEPATITIS B REACTIVATION 8 0.0025
149 HEPATITIS VIRAL 2 0.0025
150 PROCEDURAL NAUSEA 2 0.0025
151 PARVOVIRUS INFECTION 1 0.0025
152 ACUTE LYMPHOCYTIC LEUKAEMIA 7 0.0025
153 OROPHARYNGEAL PLAQUE 1 0.0025
154 PSEUDOMONAS TEST POSITIVE 2 0.0024
155 FUNGAL SEPSIS 2 0.0024
156 STARVATION 2 0.0024
157 WHITE MATTER LESION 3 0.0024
158 ABDOMINAL CAVITY DRAINAGE 1 0.0024
159 B-CELL LYMPHOMA 8 0.0024
160 PLATELET TRANSFUSION 3 0.0023
161 MIXED LIVER INJURY 7 0.0023
162 LYMPHOCYTOSIS 5 0.0023
163 VENTRICULAR DYSFUNCTION 6 0.0023
164 INTESTINAL PSEUDO-OBSTRUCTION 2 0.0023
165 POSTRENAL FAILURE 1 0.0023
166 FOLLICULAR LYMPHOMA 2 0.0023
167 PACKED RED BLOOD CELL TRANSFUSION 3 0.0023
168 PLASMA CELL MYELOMA REFRACTORY 3 0.0022
169 MENINGOENCEPHALITIS HERPETIC 1 0.0022
170 MONOPARESIS 4 0.0022
171 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 13 0.0022
172 MENINGITIS VIRAL 3 0.0022
173 CENTRAL NERVOUS SYSTEM LYMPHOMA 3 0.0022
174 EPIDERMOLYSIS 1 0.0022
175 HAEMOCHROMATOSIS 2 0.0022
176 DEATH NEONATAL 3 0.0022
177 TRANSPLANT 5 0.0021
178 NEUTROPENIC SEPSIS 15 0.0021
179 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
180 WOUND NECROSIS 1 0.0021
181 BONE MARROW FAILURE 42 0.0021
182 MUCOSAL INFLAMMATION 54 0.0021
183 UROSEPSIS 19 0.0021
184 TORSADE DE POINTES 16 0.0020
185 THERAPY RESPONDER 1 0.0020
186 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
187 CSF TEST ABNORMAL 1 0.0020
188 ACUTE RESPIRATORY DISTRESS SYNDROME 35 0.0020
189 CAPILLARY LEAK SYNDROME 4 0.0019
190 INFECTIOUS COLITIS 1 0.0019
191 SALIVARY GLAND ENLARGEMENT 1 0.0019
192 TRANSVERSE SINUS THROMBOSIS 1 0.0019
193 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
194 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
195 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
196 INTRACRANIAL VENOUS SINUS THROMBOSIS 2 0.0019
197 MEASLES 1 0.0019
198 TUMOUR LYSIS SYNDROME 16 0.0018
199 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
200 MYELODYSPLASTIC SYNDROME 26 0.0018
201 ENDOMETRIAL THICKENING 1 0.0018
202 CYSTITIS HAEMORRHAGIC 7 0.0017
203 NEPHROGENIC DIABETES INSIPIDUS 2 0.0017
204 MUCOSAL HAEMORRHAGE 2 0.0017
205 URETHRAL PAIN 1 0.0017
206 HEPATITIS FULMINANT 5 0.0017
207 ANTEROGRADE AMNESIA 1 0.0017
208 ESCHERICHIA TEST POSITIVE 2 0.0017
209 ENCEPHALOPATHY 41 0.0017
210 POST PROCEDURAL INFLAMMATION 1 0.0016
211 ADENOCARCINOMA OF COLON 3 0.0016
212 PLEURAL DISORDER 1 0.0016
213 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
214 METASTASES TO PELVIS 1 0.0016
215 VENTRICULAR HYPOKINESIA 5 0.0016
216 REFLEXES ABNORMAL 1 0.0015
217 PARANEOPLASTIC SYNDROME 1 0.0015
218 BLOOD PHOSPHORUS INCREASED 4 0.0015
219 VIRAEMIA 2 0.0014
220 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
221 RETINAL VEIN THROMBOSIS 1 0.0014
222 PULMONARY VENO-OCCLUSIVE DISEASE 1 0.0014
223 FUSARIUM INFECTION 1 0.0014
224 PROTHROMBIN TIME SHORTENED 2 0.0014
225 BRONCHOPULMONARY ASPERGILLOSIS 11 0.0014
226 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
227 TONGUE PARALYSIS 1 0.0014
228 CERVIX DISORDER 1 0.0014
229 HODGKIN'S DISEASE 1 0.0014
230 DISEASE PROGRESSION 163 0.0014
231 ASPERGILLUS INFECTION 9 0.0014
232 CLONIC CONVULSION 1 0.0014
233 MULTIPLE ORGAN DYSFUNCTION SYNDROME 38 0.0013
234 MICTURITION FREQUENCY DECREASED 1 0.0013
235 PAPILLOEDEMA 6 0.0013
236 BASOPHIL COUNT INCREASED 1 0.0013
237 INFECTIOUS PLEURAL EFFUSION 2 0.0013
238 OVARIAN NEOPLASM 1 0.0013
239 CYTOPENIA 16 0.0013
240 ENCEPHALITIS 9 0.0013
241 INTESTINAL ISCHAEMIA 7 0.0013
242 DIARRHOEA INFECTIOUS 1 0.0013
243 HERPES ZOSTER DISSEMINATED 1 0.0012
244 SKIN BACTERIAL INFECTION 1 0.0012
245 PERFORATION 1 0.0012
246 ENTEROCOCCAL SEPSIS 1 0.0012
247 VASCULAR ACCESS COMPLICATION 1 0.0012
248 SPUTUM CULTURE POSITIVE 1 0.0012
249 HYPOGAMMAGLOBULINAEMIA 8 0.0012
250 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
251 HEPATORENAL SYNDROME 2 0.0012
252 ACIDOSIS 9 0.0012
253 ENTERITIS INFECTIOUS 2 0.0012
254 DEAFNESS TRANSITORY 1 0.0012
255 HEPATIC CANCER METASTATIC 1 0.0012
256 HEPATOSPLENOMEGALY 3 0.0012
257 ENTEROVIRUS INFECTION 1 0.0012
258 PULMONARY CAVITATION 1 0.0011
259 HILAR LYMPHADENOPATHY 1 0.0011
260 TYPE I HYPERSENSITIVITY 4 0.0011
261 PARAPARESIS 2 0.0011
262 HEPATOTOXICITY 25 0.0011
263 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
264 INTESTINAL INFARCTION 1 0.0011
265 FEBRILE NEUTROPENIA 72 0.0011
266 AGRANULOCYTOSIS 20 0.0011
267 PROTHROMBIN LEVEL DECREASED 1 0.0011
268 PNEUMONIA CRYPTOCOCCAL 1 0.0011
269 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
270 PANCYTOPENIA 59 0.0011
271 BONE MARROW TRANSPLANT 2 0.0011
272 NEUTROPHILIA 6 0.0011
273 TUMOUR HAEMORRHAGE 3 0.0011
274 NEUTROPENIC INFECTION 1 0.0010
275 ENTEROCOLITIS 6 0.0010
276 HYPOALBUMINAEMIA 8 0.0010
277 BONE MARROW DEPRESSION 1 0.0010
278 HYPERTRIGLYCERIDAEMIA 6 0.0010
279 EYE MOVEMENT DISORDER 7 0.0010
280 SEPTIC SHOCK 44 0.0010
281 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
282 CELL DEATH 2 0.0010
283 BLOOD DISORDER 8 0.0010
284 CYTOKINE RELEASE SYNDROME 20 0.0010
285 LYMPHOCYTIC INFILTRATION 1 0.0010
286 DUODENAL ULCER 7 0.0010
287 INCORRECT PRODUCT STORAGE 13 0.0010
288 BLADDER DYSFUNCTION 1 0.0010
289 DIVERTICULAR PERFORATION 2 0.0010
290 QUADRIPLEGIA 2 0.0010
291 AXILLARY MASS 1 0.0010
292 OEDEMA MUCOSAL 1 0.0010
293 HYPOPERFUSION 1 0.0010
294 SINUSITIS BACTERIAL 1 0.0009
295 SYSTOLIC DYSFUNCTION 1 0.0009
296 PHARYNGEAL ERYTHEMA 2 0.0009
297 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
298 ANAEMIA MACROCYTIC 2 0.0009
299 CATHETER SITE ERYTHEMA 2 0.0009
300 KIDNEY ENLARGEMENT 1 0.0009
301 HAEMODYNAMIC INSTABILITY 7 0.0009
302 PRODUCT NAME CONFUSION 1 0.0009
303 BLOOD CALCIUM INCREASED 8 0.0009
304 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
305 EPSTEIN-BARR VIRAEMIA 1 0.0009
306 SOFT TISSUE DISORDER 1 0.0009
307 NEPHRITIS 3 0.0009
308 PARESIS 2 0.0009
309 MENINGITIS ASEPTIC 4 0.0009
310 MYOCARDIAL INJURY 1 0.0009
311 ANAL INCONTINENCE 8 0.0009
312 ACUTE PRERENAL FAILURE 1 0.0009
313 BILIRUBIN CONJUGATED INCREASED 2 0.0009
314 RECTAL ULCER 1 0.0009
315 HYPERTENSIVE EMERGENCY 1 0.0008
316 HAEMATOTOXICITY 8 0.0008
317 THERAPY PARTIAL RESPONDER 13 0.0008
318 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
319 CARDIAC DEATH 1 0.0008
320 SECONDARY IMMUNODEFICIENCY 1 0.0008
321 THROMBOCYTOSIS 3 0.0008
322 BLOOD BILIRUBIN INCREASED 22 0.0008
323 ANURIA 7 0.0008
324 CARDIOMYOPATHY 12 0.0008
325 PALATAL OEDEMA 1 0.0008
326 HELICOBACTER GASTRITIS 1 0.0008
327 LEUKOENCEPHALOPATHY 3 0.0008
328 RECTAL TENESMUS 1 0.0008
329 PROTEIN TOTAL DECREASED 3 0.0008
330 HYPOMAGNESAEMIA 11 0.0008
331 NECROTISING COLITIS 1 0.0008
332 MASS 11 0.0008
333 SEROMA 1 0.0008
334 BRONCHIAL SECRETION RETENTION 1 0.0008
335 ENTERITIS 5 0.0008
336 HEPATOCELLULAR INJURY 11 0.0008
337 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
338 CATHETER SITE PAIN 2 0.0008
339 RHINOVIRUS INFECTION 3 0.0008
340 RETINAL DEGENERATION 1 0.0008
341 EXTRADURAL HAEMATOMA 1 0.0008
342 ATRIAL FLUTTER 6 0.0008
343 POLYNEUROPATHY 9 0.0008
344 CYSTITIS NONINFECTIVE 1 0.0007
345 GLYCOSURIA 1 0.0007
346 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
347 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
348 THROMBOCYTOPENIA 82 0.0007
349 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
350 RESPIRATORY DISTRESS 20 0.0007
351 ASCITES 21 0.0007
352 ENDOTRACHEAL INTUBATION 2 0.0007
353 NEPHROPATHY TOXIC 8 0.0007
354 HEPATOMEGALY 7 0.0007
355 LIP OEDEMA 3 0.0007
356 HEMIPARESIS 12 0.0007
357 NEUTROPHIL COUNT ABNORMAL 2 0.0007
358 NEUROENDOCRINE TUMOUR 1 0.0007
359 BLOOD ELECTROLYTES DECREASED 1 0.0007
360 PRODUCT STORAGE ERROR 61 0.0007
361 PARAPLEGIA 2 0.0007
362 ADENOVIRUS INFECTION 2 0.0007
363 MUTISM 1 0.0007
364 LYMPHOPROLIFERATIVE DISORDER 2 0.0007
365 HYPERBILIRUBINAEMIA 7 0.0007
366 BACTERAEMIA 8 0.0007
367 ATYPICAL PNEUMONIA 2 0.0007
368 GASTROINTESTINAL WALL THICKENING 1 0.0007
369 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
370 MALIGNANT NEOPLASM PROGRESSION 68 0.0007
371 SMALL CELL LUNG CANCER 1 0.0007
372 KERATITIS 2 0.0007
373 ACUTE GRAFT VERSUS HOST DISEASE 3 0.0007
374 DISEASE COMPLICATION 3 0.0007
375 IMMUNE THROMBOCYTOPENIA 3 0.0007
376 GENITAL HERPES 1 0.0007
377 DUODENITIS 2 0.0007
378 MYELITIS 1 0.0006
379 EJECTION FRACTION DECREASED 10 0.0006
380 SINUS ARREST 1 0.0006
381 HEPATITIS E 1 0.0006
382 INTESTINAL OPERATION 1 0.0006
383 RENAL CYST 5 0.0006
384 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
385 CHOLESTASIS 12 0.0006
386 HAEMOGLOBIN ABNORMAL 4 0.0006
387 ORGANISING PNEUMONIA 3 0.0006
388 RESUSCITATION 1 0.0006
389 KLEBSIELLA INFECTION 3 0.0006
390 LEUKAEMIA RECURRENT 1 0.0006
391 INCORRECT STORAGE OF DRUG 1 0.0006
392 HYPERREFLEXIA 2 0.0006
393 SPLENIC INFARCTION 1 0.0006
394 FANCONI SYNDROME ACQUIRED 1 0.0006
395 BRONCHIOLITIS 2 0.0006
396 GASTROINTESTINAL OEDEMA 1 0.0006
397 ILEAL STENOSIS 1 0.0006
398 FIBRIN D DIMER INCREASED 2 0.0006
399 GRAFT VERSUS HOST DISEASE 4 0.0006
400 BONE LESION 2 0.0006
401 MONOCYTE COUNT INCREASED 2 0.0006
402 HYDROCEPHALUS 3 0.0006
403 PATHOGEN RESISTANCE 5 0.0005
404 ASTHMATIC CRISIS 2 0.0005
405 NEOPLASM PROGRESSION 19 0.0005
406 SINUS NODE DYSFUNCTION 1 0.0005
407 PNEUMONIA KLEBSIELLA 1 0.0005
408 ACUTE KIDNEY INJURY 83 0.0005
409 HYPOKALAEMIA 25 0.0005
410 CYSTOID MACULAR OEDEMA 1 0.0005
411 MYELOPATHY 1 0.0005
412 MECHANICAL VENTILATION 1 0.0005
413 PANCREATIC CYST 1 0.0005
414 MYOCARDITIS 6 0.0005
415 BLOOD URIC ACID INCREASED 3 0.0005
416 ARTERIAL THROMBOSIS 1 0.0005
417 ELECTROLYTE IMBALANCE 6 0.0005
418 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
419 THROMBOTIC MICROANGIOPATHY 5 0.0005
420 OCCULT BLOOD POSITIVE 1 0.0005
421 HYPERAEMIA 1 0.0005
422 DISEASE RECURRENCE 24 0.0005
423 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
424 SALIVARY HYPERSECRETION 5 0.0005
425 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
426 PLATELET COUNT ABNORMAL 3 0.0005
427 ADRENAL INSUFFICIENCY 6 0.0005
428 NEUTROPHIL COUNT INCREASED 5 0.0005
429 ANAPHYLACTOID REACTION 2 0.0005
430 HAIR DISORDER 4 0.0005
431 OLIGURIA 3 0.0005
432 CYTOMEGALOVIRUS INFECTION 8 0.0005
433 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
434 CONGESTIVE CARDIOMYOPATHY 2 0.0005
435 DILATATION VENTRICULAR 1 0.0005
436 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
437 HEPATIC CYTOLYSIS 6 0.0005
438 C-REACTIVE PROTEIN INCREASED 17 0.0005
439 CD4 LYMPHOCYTES DECREASED 1 0.0005
440 CARDIAC FLUTTER 3 0.0005
441 METASTATIC NEOPLASM 2 0.0005
442 HEPATIC LESION 2 0.0005
443 HERPES SIMPLEX 3 0.0005
444 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
445 NEUROTOXICITY 8 0.0005
446 CLOSTRIDIUM TEST POSITIVE 1 0.0005
447 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
448 PNEUMOCYSTIS JIROVECI PNEUMONIA 1 0.0004
449 BASAL CELL CARCINOMA 7 0.0004
450 NEUTROPENIA 61 0.0004
451 PSEUDOMEMBRANOUS COLITIS 1 0.0004
452 LIVER FUNCTION TEST ABNORMAL 13 0.0004
453 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
454 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
455 LEUKOCYTOSIS 8 0.0004
456 TACHYPNOEA 6 0.0004
457 KOUNIS SYNDROME 1 0.0004
458 HAEMATOCRIT INCREASED 1 0.0004
459 CYTOMEGALOVIRUS COLITIS 1 0.0004
460 LARGE INTESTINE PERFORATION 3 0.0004
461 HEPATIC FAILURE 13 0.0004
462 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
463 BACTERIAL INFECTION 8 0.0004
464 ESCHERICHIA BACTERAEMIA 1 0.0004
465 LEUKAEMIA 4 0.0004
466 SEPSIS 47 0.0004
467 RETINAL HAEMORRHAGE 3 0.0004
468 COMA 20 0.0004
469 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
470 OXYGEN CONSUMPTION INCREASED 1 0.0004
471 CARDIOGENIC SHOCK 6 0.0004
472 DIABETES INSIPIDUS 1 0.0004
473 WRONG DOSE 1 0.0004
474 LUNG DISORDER 20 0.0004
475 STAPHYLOCOCCAL SEPSIS 2 0.0004
476 INFLAMMATORY MARKER INCREASED 2 0.0004
477 SMALL FOR DATES BABY 2 0.0004
478 TACHYARRHYTHMIA 1 0.0004
479 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
480 DERMATITIS EXFOLIATIVE 2 0.0004
481 SYSTEMIC CANDIDA 1 0.0004
482 PLATELET DISORDER 1 0.0004
483 METASTASES TO PERITONEUM 1 0.0004
484 RETINAL ARTERY OCCLUSION 1 0.0004
485 URINARY TRACT INFECTION BACTERIAL 1 0.0004
486 TROPONIN INCREASED 3 0.0004
487 INCREASED BRONCHIAL SECRETION 1 0.0004
488 PERICARDIAL EFFUSION 9 0.0004
489 BLOOD CHLORIDE DECREASED 1 0.0004
490 ACUTE MYELOID LEUKAEMIA 6 0.0004
491 PULMONARY HAEMORRHAGE 3 0.0004
492 COMPARTMENT SYNDROME 1 0.0004
493 PRODUCT USE IN UNAPPROVED INDICATION 93 0.0004
494 URINARY INCONTINENCE 11 0.0004
495 COLITIS 14 0.0004
496 OESOPHAGITIS 4 0.0004
497 ORAL FUNGAL INFECTION 1 0.0004
498 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
499 PLEURAL EFFUSION 22 0.0004
500 GASTRIC ULCER HAEMORRHAGE 2 0.0004
501 INTRACRANIAL PRESSURE INCREASED 2 0.0004
502 MALNUTRITION 4 0.0004
503 PROCTITIS 1 0.0004
504 RENAL TUBULAR DISORDER 1 0.0004
505 SKIN TOXICITY 2 0.0004
506 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
507 LYMPHOPENIA 5 0.0004
508 FACIAL PARALYSIS 3 0.0004
509 RESPIRATORY SYMPTOM 1 0.0004
510 SUBDURAL HAEMATOMA 5 0.0003
511 COMA SCALE ABNORMAL 1 0.0003
512 ESCHERICHIA SEPSIS 1 0.0003
513 MADAROSIS 4 0.0003
514 ANAPHYLACTIC REACTION 19 0.0003
515 GASTROINTESTINAL NECROSIS 1 0.0003
516 HYPOXIA 12 0.0003
517 PLEURISY 2 0.0003
518 MYOSITIS 3 0.0003
519 HEPATITIS CHOLESTATIC 2 0.0003
520 HIV INFECTION 1 0.0003
521 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
522 APHASIA 10 0.0003
523 BONE MARROW DISORDER 1 0.0003
524 DEVICE RELATED INFECTION 5 0.0003
525 LYMPHOMA 5 0.0003
526 CHOLANGITIS 2 0.0003
527 HAIR COLOUR CHANGES 4 0.0003
528 NON-CARDIAC CHEST PAIN 1 0.0003
529 ORTHOPNOEA 1 0.0003
530 STUPOR 1 0.0003
531 ANAEMIA 59 0.0003
532 HYPOVENTILATION 1 0.0003
533 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
534 VISUAL ACUITY REDUCED 10 0.0003
535 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
536 HAIR TEXTURE ABNORMAL 4 0.0003
537 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
538 POTENTIATING DRUG INTERACTION 1 0.0003
539 METASTASES TO SPINE 1 0.0003
540 BK VIRUS INFECTION 1 0.0003
541 METASTASES TO LYMPH NODES 2 0.0003
542 NEOPLASM RECURRENCE 1 0.0003
543 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
544 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
545 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
546 AUTOIMMUNE HEPATITIS 2 0.0003
547 THROMBOPHLEBITIS 1 0.0003
548 JAUNDICE CHOLESTATIC 1 0.0003
549 LYMPHOCYTE COUNT DECREASED 5 0.0003
550 SINUS TACHYCARDIA 4 0.0003
551 CONJUNCTIVAL HYPERAEMIA 1 0.0003
552 BRONCHOSPASM 4 0.0003
553 RENAL TRANSPLANT 1 0.0003
554 SCLERODERMA 1 0.0003
555 LIVER TRANSPLANT 1 0.0003
556 FLUID OVERLOAD 4 0.0003
557 RASH PUSTULAR 2 0.0003
558 MOUTH HAEMORRHAGE 2 0.0003
559 HYPOPHOSPHATAEMIA 2 0.0003
560 INTESTINAL PERFORATION 3 0.0003
561 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
562 STOMATITIS 16 0.0003
563 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
564 PLATELET COUNT DECREASED 28 0.0003
565 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
566 NEOPLASM 3 0.0003
567 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
568 LUNG INFECTION 4 0.0003
569 PNEUMONITIS 7 0.0003
570 SPINAL CORD COMPRESSION 1 0.0003
571 TESTIS CANCER 1 0.0003
572 VENOUS THROMBOSIS 1 0.0003
573 PNEUMONIA FUNGAL 1 0.0003
574 BLOOD ALBUMIN DECREASED 2 0.0003
575 CEREBRAL ATROPHY 1 0.0003
576 ARTERIOSPASM CORONARY 1 0.0002
577 MIOSIS 2 0.0002
578 LACTIC ACIDOSIS 8 0.0002
579 SHOCK HAEMORRHAGIC 2 0.0002
580 SMALL INTESTINAL OBSTRUCTION 3 0.0002
581 METASTASES TO BONE 4 0.0002
582 EXTRAVASATION 1 0.0002
583 GENERALISED OEDEMA 3 0.0002
584 SPINAL STENOSIS 1 0.0002
585 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
586 ACUTE CORONARY SYNDROME 2 0.0002
587 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
588 LEUKOPENIA 12 0.0002
589 HAEMODIALYSIS 2 0.0002
590 PERICARDITIS 4 0.0002
591 FACE OEDEMA 4 0.0002
592 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
593 CANDIDA INFECTION 4 0.0002
594 BUNDLE BRANCH BLOCK LEFT 1 0.0002
595 ABSCESS LIMB 1 0.0002
596 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
597 DRUG RESISTANCE 6 0.0002
598 PSEUDOMONAS INFECTION 2 0.0002
599 SYNCOPE 23 0.0002
600 EPILEPSY 7 0.0002
601 OFF LABEL USE 200 0.0002
602 RENAL IMPAIRMENT 19 0.0002
603 SEIZURE 26 0.0002
604 MYELOSUPPRESSION 8 0.0002
605 SUSPECTED OFF LABEL USE 1 0.0002
606 PERIPHERAL COLDNESS 3 0.0002
607 SHOCK 5 0.0002
608 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
609 HAEMOPTYSIS 6 0.0002
610 BLOOD CREATININE INCREASED 14 0.0002
611 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
612 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
613 CARDIAC TAMPONADE 1 0.0002
614 PULMONARY FIBROSIS 4 0.0002
615 FAECAL INCONTINENCE 1 0.0002
616 ENTEROCOCCAL INFECTION 1 0.0002
617 GUILLAIN-BARRE SYNDROME 1 0.0002
618 PYREXIA 71 0.0002
619 LIVER DISORDER 9 0.0002
620 BREATH SOUNDS ABNORMAL 1 0.0002
621 HYPERVOLAEMIA 1 0.0002
622 PULMONARY MASS 3 0.0002
623 ABDOMINAL TENDERNESS 1 0.0002
624 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
625 VEIN DISORDER 1 0.0002
626 TOXIC ENCEPHALOPATHY 1 0.0002
627 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
628 SUBARACHNOID HAEMORRHAGE 2 0.0002
629 NEUTROPHIL COUNT DECREASED 8 0.0002
630 MOTOR DYSFUNCTION 2 0.0002
631 PETIT MAL EPILEPSY 1 0.0002
632 HEPATITIS 5 0.0002
633 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
634 RESPIRATORY TRACT INFECTION 5 0.0002
635 TENDERNESS 2 0.0002
636 DEAFNESS 5 0.0002
637 HYPOTHYROIDISM 6 0.0002
638 VIROLOGIC FAILURE 1 0.0002
639 ATRIAL FIBRILLATION 18 0.0002
640 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
641 RENAL FAILURE 24 0.0002
642 TRANSAMINASES INCREASED 4 0.0002
643 RASH MACULO-PAPULAR 4 0.0002
644 DYSPHAGIA 17 0.0002
645 ACUTE PULMONARY OEDEMA 1 0.0002
646 STATUS EPILEPTICUS 2 0.0002
647 CHOLECYSTITIS ACUTE 1 0.0002
648 CIRCULATORY COLLAPSE 3 0.0002
649 HAEMATURIA 6 0.0002
650 CARDIAC FAILURE 14 0.0002
651 HERPES VIRUS INFECTION 1 0.0002
652 RALES 1 0.0002
653 BLINDNESS 7 0.0002
654 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
655 COVID-19 PNEUMONIA 2 0.0002
656 ARRHYTHMIA 8 0.0002
657 TACHYCARDIA 15 0.0002
658 HEPATITIS B 1 0.0002
659 RENAL FAILURE ACUTE 7 0.0002
660 CARDIOMEGALY 2 0.0002
661 SCOLIOSIS 1 0.0002
662 ILEUS 2 0.0002
663 AGGRESSION 8 0.0002
664 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
665 HYPOCALCAEMIA 3 0.0002
666 BRAIN OEDEMA 2 0.0002
667 PHOTOPSIA 1 0.0002
668 HYPOPHAGIA 4 0.0002
669 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
670 ANAPHYLACTIC SHOCK 4 0.0002
671 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
672 PRESCRIBED OVERDOSE 3 0.0002
673 INCOHERENT 1 0.0002
674 DIPLOPIA 4 0.0002
675 DEEP VEIN THROMBOSIS 10 0.0002
676 ORAL CANDIDIASIS 2 0.0002
677 ADVERSE REACTION 2 0.0002
678 CARDIAC FAILURE ACUTE 1 0.0001
679 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
680 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
681 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
682 RIGHT VENTRICULAR FAILURE 1 0.0001
683 MOUTH ULCERATION 3 0.0001
684 PAPULE 1 0.0001
685 DIALYSIS 2 0.0001
686 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
687 PANIC REACTION 1 0.0001
688 DERMATITIS BULLOUS 1 0.0001
689 RESPIRATORY FAILURE 10 0.0001
690 COVID-19 24 0.0001
691 MELAENA 3 0.0001
692 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
693 HYDRONEPHROSIS 1 0.0001
694 PRODUCT USE ISSUE 25 0.0001
695 HEPATIC ENZYME INCREASED 9 0.0001
696 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
697 HYPERTHERMIA 1 0.0001
698 DRUG DISPENSING ERROR 2 0.0001
699 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
700 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
701 PNEUMOTHORAX 2 0.0001
702 CYSTITIS 4 0.0001
703 ABSCESS 2 0.0001
704 TRANSPLANT REJECTION 1 0.0001
705 RHINITIS 1 0.0001
706 CONFUSIONAL STATE 20 0.0001
707 MUSCLE TIGHTNESS 2 0.0001
708 HICCUPS 1 0.0001
709 HYPERAESTHESIA 1 0.0001
710 ESCHERICHIA INFECTION 1 0.0001
711 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
712 TREATMENT FAILURE 10 0.0001
713 EMBOLISM 1 0.0001
714 LIVE BIRTH 1 0.0001
715 BLOOD UREA INCREASED 2 0.0001
716 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
717 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
718 HAEMATEMESIS 3 0.0001
719 BLOOD MAGNESIUM DECREASED 1 0.0001
720 PSYCHOLOGICAL TRAUMA 1 0.0001
721 NEUROPATHY PERIPHERAL 11 0.0001
722 PYELONEPHRITIS 1 0.0001
723 ILL-DEFINED DISORDER 7 0.0001
724 SKIN SWELLING 1 0.0001
725 DRUG INTOLERANCE 11 0.0001
726 IMMUNOSUPPRESSION 1 0.0001
727 PRODUCT COMMUNICATION ISSUE 1 0.0001
728 LUNG INFILTRATION 1 0.0001
729 LYMPHADENOPATHY 4 0.0001
730 HAEMARTHROSIS 1 0.0001
731 OROPHARYNGEAL DISCOMFORT 1 0.0001
732 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
733 PALLOR 3 0.0001
734 HYPERGLYCAEMIA 4 0.0001
735 HYPOTENSION 22 0.0001
736 DYSURIA 4 0.0001
737 IRON DEFICIENCY ANAEMIA 1 0.0001
738 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
739 AMNESIA 7 0.0001
740 HEPATIC FUNCTION ABNORMAL 4 0.0001
741 APPENDICITIS 1 0.0001
742 DIARRHOEA HAEMORRHAGIC 1 0.0001
743 OXYGEN SATURATION DECREASED 6 0.0001
744 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
745 FLANK PAIN 1 0.0001
746 HYPONATRAEMIA 6 0.0001
747 PNEUMONIA 34 0.0001
748 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
749 INTERSTITIAL LUNG DISEASE 5 0.0001
750 HYPOGLYCAEMIA 5 0.0001
751 AUTOIMMUNE DISORDER 1 0.0001
752 BONE PAIN 6 0.0001
753 RENAL TUBULAR NECROSIS 1 0.0001
754 ACUTE MYOCARDIAL INFARCTION 3 0.0001
755 VITREOUS FLOATERS 1 0.0001
756 HOSPICE CARE 1 0.0001
757 GASTROINTESTINAL DISORDER 9 0.0001
758 RESPIRATORY DISORDER 3 0.0001
759 OVARIAN CYST 1 0.0001
760 PERITONITIS BACTERIAL 1 0.0001
761 PRODUCT PREPARATION ERROR 2 0.0001
762 WEIGHT FLUCTUATION 1 0.0001
763 TRANSFUSION 1 0.0001
764 TOXICITY TO VARIOUS AGENTS 16 0.0001
765 PANCREATITIS 5 0.0001
766 ABDOMINAL PAIN 22 0.0001
767 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
768 EPISTAXIS 7 0.0001
769 CONDITION AGGRAVATED 28 0.0001
770 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
771 HYPERSENSITIVITY 17 0.0001
772 WOUND INFECTION 1 0.0001
773 LIP SWELLING 3 0.0001
774 VENTRICULAR FIBRILLATION 1 0.0001
775 THERAPY NON-RESPONDER 4 0.0001
776 PANCREATITIS ACUTE 2 0.0001
777 MITRAL VALVE INCOMPETENCE 1 0.0001
778 DRUG INTERACTION 14 0.0001
779 HERPES ZOSTER 5 0.0001
780 GASTRIC HAEMORRHAGE 1 0.0001
781 HYPOAESTHESIA 13 0.0001
782 ALOPECIA 17 0.0001
783 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
784 EYELID OEDEMA 1 0.0001
785 SPLENOMEGALY 1 0.0001
786 CHILLS 10 0.0001
787 ATAXIA 1 0.0001
788 PULMONARY EMBOLISM 8 0.0001
789 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
790 NEURALGIA 2 0.0001
791 LIVER INJURY 2 0.0001
792 TENDON RUPTURE 1 0.0001
793 CYST 1 0.0001
794 MUSCLE ATROPHY 1 0.0001
795 FLUSHING 8 0.0001
796 CHEST DISCOMFORT 8 0.0001
797 MYDRIASIS 1 0.0001
798 INFLAMMATION 4 0.0001
799 PLATELET COUNT INCREASED 1 0.0001
800 BEDRIDDEN 1 0.0001
801 INFECTION 11 0.0001
802 THROAT TIGHTNESS 2 0.0001
803 OEDEMA PERIPHERAL 9 0.0001
804 OEDEMA 4 0.0001
805 CORONARY ARTERY OCCLUSION 1 0.0001
806 VISION BLURRED 10 0.0001
807 DIVERTICULITIS 2 0.0001
808 WEIGHT INCREASED 16 0.0001
809 DEVICE OCCLUSION 1 0.0001
810 CEREBROVASCULAR ACCIDENT 12 0.0001
811 PARALYSIS 1 0.0001
812 SOMNOLENCE 14 0.0001
813 HYPERTHYROIDISM 1 0.0001
814 HYPOKINESIA 1 0.0001
815 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
816 ANGIOEDEMA 3 0.0001
817 DYSPNOEA 38 0.0001
818 IMMUNODEFICIENCY 1 0.0001
819 VOMITING 31 0.0001
820 URTICARIA 11 0.0001
821 PHARYNGEAL OEDEMA 1 0.0001
822 DRUG-INDUCED LIVER INJURY 2 0.0001
823 CYANOSIS 1 0.0001
824 PREMATURE DELIVERY 1 0.0001
825 DEATH 54 0.0001
826 CARDIAC FAILURE CONGESTIVE 5 0.0001
827 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
828 STAPHYLOCOCCAL INFECTION 2 0.0001
829 VIRAL INFECTION 2 0.0001
830 COAGULOPATHY 1 0.0001
831 FUNGAL INFECTION 2 0.0001
832 CHEST PAIN 11 0.0001
833 DIARRHOEA 38 0.0001
834 ASTHENIA 22 0.0001
835 ERYTHEMA 12 0.0001
836 MULTI-ORGAN FAILURE 1 0.0001
837 DELIRIUM 2 0.0001
838 LOCAL SWELLING 1 0.0001
839 HYPERKALAEMIA 2 0.0001
840 COLD SWEAT 1 0.0001
841 BRADYCARDIA 3 0.0001
842 CEREBRAL HAEMORRHAGE 2 0.0001
843 PELVIC PAIN 1 0.0001
844 LOSS OF CONSCIOUSNESS 7 0.0001
845 CONJUNCTIVITIS 1 0.0001
846 INFLUENZA 6 0.0001
847 COUGH 15 0.0001
848 DYSPNOEA EXERTIONAL 2 0.0001
849 PROTEINURIA 1 0.0001
850 DEHYDRATION 7 0.0001
851 SEROTONIN SYNDROME 1 0.0001
852 DRUG INEFFECTIVE 68 0.0001
853 DYSPHONIA 3 0.0001
854 CARDIO-RESPIRATORY ARREST 2 0.0000
855 EATING DISORDER 1 0.0000
856 RETCHING 1 0.0000
857 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
858 INFUSION RELATED REACTION 3 0.0000
859 NEOPLASM MALIGNANT 3 0.0000
860 PULMONARY OEDEMA 2 0.0000
861 RASH PAPULAR 1 0.0000
862 MUSCULAR WEAKNESS 5 0.0000
863 SKIN DISCOLOURATION 2 0.0000
864 ADVERSE EVENT 4 0.0000
865 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
866 LOCALISED INFECTION 1 0.0000
867 MENTAL IMPAIRMENT 1 0.0000
868 DYSPEPSIA 4 0.0000
869 CARDIOVASCULAR DISORDER 1 0.0000
870 FLUID RETENTION 2 0.0000
871 SKIN ULCER 1 0.0000
872 NO ADVERSE EVENT 7 0.0000
873 HAEMATOMA 1 0.0000
874 JAUNDICE 1 0.0000
875 SKIN LESION 1 0.0000
876 MENTAL STATUS CHANGES 1 0.0000
877 INTENTIONAL DOSE OMISSION 1 0.0000
878 RED BLOOD CELL COUNT DECREASED 1 0.0000
879 CONVULSION 2 0.0000
880 ANGINA PECTORIS 1 0.0000
881 RASH 15 0.0000
882 NASAL CONGESTION 2 0.0000
883 RENAL INJURY 1 0.0000
884 HEADACHE 21 0.0000
885 IRRITABILITY 2 0.0000
886 PREMATURE BABY 1 0.0000
887 HYPERTENSION 7 0.0000
888 CORONARY ARTERY DISEASE 1 0.0000
889 THERAPEUTIC RESPONSE DECREASED 2 0.0000
890 DRUG ADMINISTRATION ERROR 1 0.0000
891 FEMUR FRACTURE 1 0.0000
892 NERVOUS SYSTEM DISORDER 1 0.0000
893 SWOLLEN TONGUE 1 0.0000
894 PARAESTHESIA 5 0.0000
895 METABOLIC ACIDOSIS 1 0.0000
896 HYPERHIDROSIS 4 0.0000
897 NIGHT SWEATS 1 0.0000
898 CHOLELITHIASIS 1 0.0000
899 HEART RATE INCREASED 3 0.0000
900 EYE PRURITUS 1 0.0000
901 ANGER 1 0.0000
902 HAEMOGLOBIN DECREASED 3 0.0000
903 NAUSEA 23 0.0000
904 NIGHTMARE 1 0.0000
905 BURNING SENSATION 2 0.0000
906 DEVICE MALFUNCTION 2 0.0000
907 BRONCHITIS 2 0.0000
908 DYSARTHRIA 1 0.0000
909 INTESTINAL OBSTRUCTION 1 0.0000
910 UNEVALUABLE EVENT 2 0.0000
911 GAIT DISTURBANCE 5 0.0000
912 BACK PAIN 6 0.0000
913 PLASMA CELL MYELOMA 1 0.0000
914 PALPITATIONS 3 0.0000
915 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
916 DISORIENTATION 1 0.0000
917 WEIGHT DECREASED 7 0.0000
918 DEVICE BREAKAGE 1 0.0000
919 DYSKINESIA 1 0.0000
920 LUNG NEOPLASM MALIGNANT 1 0.0000
921 CARDIAC ARREST 2 0.0000
922 POLLAKIURIA 1 0.0000
923 OSTEOARTHRITIS 1 0.0000
924 MYALGIA 4 0.0000
925 RECTAL HAEMORRHAGE 1 0.0000
926 HYPOACUSIS 1 0.0000
927 FATIGUE 18 0.0000
928 MENTAL DISORDER 1 0.0000
929 CONSTIPATION 5 0.0000
930 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
931 ADVERSE DRUG REACTION 2 0.0000
932 OROPHARYNGEAL PAIN 2 0.0000
933 DECREASED APPETITE 5 0.0000
934 RENAL DISORDER 1 0.0000
935 PRODUCTIVE COUGH 1 0.0000
936 MALAISE 9 0.0000
937 PAIN IN EXTREMITY 6 0.0000
938 CELLULITIS 1 0.0000
939 ABDOMINAL PAIN UPPER 4 0.0000
940 ILLNESS 2 0.0000
941 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
942 ABDOMINAL DISTENSION 2 0.0000
943 NERVOUSNESS 1 0.0000
944 SPEECH DISORDER 1 0.0000
945 PRURITUS 7 0.0000
946 HAEMATOCHEZIA 1 0.0000
947 MEDICATION ERROR 1 0.0000
948 BLISTER 1 0.0000
949 URINARY TRACT INFECTION 3 0.0000
950 FEELING ABNORMAL 4 0.0000
951 SUICIDE ATTEMPT 1 0.0000
952 FEELING HOT 1 0.0000
953 EXPOSURE DURING PREGNANCY 1 0.0000
954 FALL 5 0.0000
955 MEMORY IMPAIRMENT 2 0.0000
956 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
957 HOT FLUSH 1 0.0000
958 BLOOD PRESSURE INCREASED 2 0.0000
959 THROMBOSIS 1 0.0000
960 BALANCE DISORDER 1 0.0000
961 INTENTIONAL PRODUCT MISUSE 1 0.0000
962 MUSCULOSKELETAL STIFFNESS 1 0.0000
963 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
964 NASOPHARYNGITIS 2 0.0000
965 SWELLING 1 0.0000
966 BLOOD GLUCOSE INCREASED 2 0.0000
967 DIZZINESS 5 0.0000
968 SINUSITIS 1 0.0000
969 HAEMORRHAGE 1 0.0000
970 JOINT SWELLING 1 0.0000
971 PAIN 5 0.0000
972 INSOMNIA 2 0.0000
973 PRODUCT QUALITY ISSUE 1 0.0000
974 HOSPITALISATION 1 0.0000
975 TREMOR 1 0.0000
976 ABDOMINAL DISCOMFORT 1 0.0000
977 MYOCARDIAL INFARCTION 1 0.0000
978 MUSCLE SPASMS 1 0.0000
979 OVERDOSE 1 0.0000
980 ANXIETY 1 0.0000
981 PRODUCT DOSE OMISSION ISSUE 1 0.0000